Inhibitory effects of dietary glucosylceramides on squamous cell carcinoma of the head and neck in NOD/SCID mice

International Journal of Clinical Oncology

Volumn 16, Issue 2, 2011, Pages 133-140

  Fujiwara, Kazunori ^a   Kitatani, Kazuyuki ^a   Fukushima, Kei ^a   Yazama, Hiroaki ^a   Umehara, Hisanori ^b   Kikuchi, Mitsunori ^c   Igarashi, Yasuyuki ^d   Kitano, Hiroya ^a   Okazaki, Toshiro ^a  

^a TOTTORI UNIVERSITY   (Japan)

^b KANAZAWA MEDICAL UNIVERSITY   (Japan)

^c 1 Numata Kitagata cho   (Japan)

^d HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Apoptosis; Ceramide; Dietary glucosylceramide; Head and neck cancer; Rice bran; Squamous cell carcinoma

Indexed keywords

1 O BETA GLUCOSYL N 2' HYDROXYARACHODOYL 4,8 SPHINGADIENINE; ANTINEOPLASTIC AGENT; CASPASE 3; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CONTROLLED STUDY; DRUG MECHANISM; DRUG STRUCTURE; FEMALE; HEAD AND NECK CARCINOMA; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; TOXICITY TESTING; TUMOR XENOGRAFT;

ANIMALS; APOPTOSIS; CARCINOMA; CASPASE 3; CELL LINE, TUMOR; FEMALE; GLUCOSYLCERAMIDES; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MICE; MICE, INBRED NOD; MICE, SCID; NEOPLASMS, SQUAMOUS CELL; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 79959839785     PISSN: 13419625     EISSN: 14377772     Source Type: Journal    
DOI: 10.1007/s10147-010-0141-y     Document Type: Article

References (26)

1. Jemal A, Siegel R, Ward E et al (2007) Cancer statistics, 2007. CA Cancer J Clin 57:43-66
2. Vokes EE, Weichselbaum RR, Lippman SM et al (1993) Head and neck cancer. N Engl J Med 328:184-194
3. Chaigneau L, Guardiola E, N'Guyen T et al (2006) Induction chemotherapy in patients with head and neck cancer. Bull Cancer 93:677-682
4. Her C (2001) Nasopharyngeal cancer and the Southeast Asian patient. Am Fam Physician 63:1776-1782
5. Larson DL, Lindberg RD, Lane E et al (1983) Major complications of radiotherapy in cancer of the oral cavity and oropharynx. A 10 year retrospective study. Am J Surg 146:531-536 (Pubitemid 13012484)
6. Hannun YA (1996) Functions of ceramide in coordinating cellular responses to stress. Science 274:1855-1859
7. Okazaki T, Bell RM, Hannun YA (1989) Sphingomyelin turnover induced by vitamin D3 in HL-60 cells. Role in cell differentiation. J Biol Chem 264:19076-19080 (Pubitemid 19285812)
8. Hannun YA, Obeid LM (2008) Principles of bioactive lipid signalling: lessons from sphingolipids. Nat Rev Mol Cell Biol 9:139-150 (Pubitemid 351158911)
9. Vesper H, Schmelz EM, Nikolova-Karakashian MN et al (1999) Sphingolipids in food and the emerging importance of sphingolipids to nutrition. J Nutr 129:1239-1250 (Pubitemid 29304970)
10. Kitatani K, Idkowiak-Baldys J, Hannun YA (2008) The sphingolipid salvage pathway in ceramide metabolism and signaling. Cell Signal 20:1010-1018
11. Obeid LM, Linardic CM, Karolak LA et al (1993) Programmed cell death induced by ceramide. Science 259:1769-1771 (Pubitemid 23114667)
12. Kolesnick RN, Kronke M (1998) Regulation of ceramide production and apoptosis. Annu Rev Physiol 60:643-665
13. Inamine M, Suzui M, Morioka T et al (2005) Inhibitory effect of dietary monoglucosylceramide 1-O-beta-glucosyl-N-2′-hydroxyarachidoyl-4,8- sphingadienine on two different categories of colon preneoplastic lesions induced by 1,2-dimethylhydrazine in F344 rats. Cancer Sci 96:876-881 (Pubitemid 43056126)
14. Oku H, Wongtangtintharn S, Iwasaki H et al (2007) Tumor specific cytotoxicity of glucosylceramide. Cancer Chemother Pharmacol 60:767-775
15. Schmelz EM, Roberts PC, Kustin EM et al (2001) Modulation of intracellular beta-catenin localization and intestinal tumorigenesis in vivo and in vitro by sphingolipids. Cancer Res 61:6723-6729 (Pubitemid 32896494)
16. Merrill AH Jr, Schmelz EM, Dillehay DL et al (1997) Sphingolipids-the enigmatic lipid class: biochemistry, physiology, and pathophysiology. Toxicol Appl Pharmacol 142:208-225
17. Oku H, Li C, Shimatani M et al (2009) Tumor specific cytotoxicity of beta-glucosylceramide: structure-cytotoxicity relationship and anti-tumor activity in vivo. Cancer Chemother Pharmacol 64:485-496
18. Dillehay DL, Webb SK, Schmelz EM et al (1994) Dietary sphingomyelin inhibits 1,2-dimethylhydrazine-induced colon cancer in CF1 mice. J Nutr 124:615-620 (Pubitemid 24157280)
19. Zeisel SH, Char D, Sheard NF (1986) Choline, phosphatidylcholine and sphingomyelin in human and bovine milk and infant formulas. J Nutr 116:50-58 (Pubitemid 16212055)
20. Tsuji K, Mitsutake S, Ishikawa J et al (2006) Dietary glucosylceramide improves skin barrier function in hairless mice. J Dermatol Sci 44:101-107 (Pubitemid 44499011)
21. Ishihara S, Nieda M, Kitayama J et al (2000) Alpha-glycosylceramides enhance the antitumor cytotoxicity of hepatic lymphocytes obtained from cancer patients by activating CD3-CD56+ NK cells in vitro. J Immunol 165:1659-1664 (Pubitemid 30604605)
22. Zhou D, Mattner J, Cantu C 3rd et al (2004) Lysosomal glycosphingolipid recognition by NKT cells. Science 306:1786-1789 (Pubitemid 39601398)
23. Rossi MJ, Sundararaj K, Koybasi S et al (2005) Inhibition of growth and telomerase activity by novel cationic ceramide analogs with high solubility in human head and neck squamous cell carcinoma cells. Otolaryngol Head Neck Surg 132:55-62 (Pubitemid 40052672)
24. Senkal CE, Ponnusamy S, Rossi MJ et al (2007) Role of human longevity assurance gene 1 and C18-ceramide in chemotherapy-induced cell death in human head and neck squamous cell carcinomas. Mol Cancer Ther 6:712-722 (Pubitemid 46332472)
25. Lalazar G, Preston S, Zigmond E et al (2006) Glycolipids as immune modulatory tools. Mini Rev Med Chem 6:1249-1253
26. Shimizu K, Goto A, Fukui M et al (2007) Tumor cells loaded with alpha-galactosylceramide induce innate NKT and NK cell-dependent resistance to tumor implantation in mice. J Immunol 178:2853-2861 (Pubitemid 46333163)